Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

The document concludes that cosmetics need biocompatible, eco-friendly ingredients due to aging populations and demand for effective products.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Essential oils in cosmetics can offer benefits but may cause allergies and should be used carefully.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

CYP2B12 enzyme in skin cells converts arachidonic acid into specific bioactive lipids.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Minoxidil can harm dog's heart.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Created accurate method to measure tamsulosin hydrochloride and finasteride in tablets.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Carvone helps treat skin issues by reducing melanin and stopping harmful cell growth.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Substance abuse can cause various skin problems, including marks from injections, sores, premature aging, and increased cancer risk.

Over 150 new molecules with biological activities were found in traditional herbal medicines, some with potential for new drug development.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.